X-linked Hypophosphatemia Disease Monitoring Program
Clinical trial NCT03651505 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03651505
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2018-07-16
- Primary completion
- 2032-12-01
- Enrollment
- 782
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.